These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 12562057)

  • 1. Novel treatments for attention-deficit/hyperactivity disorder in children.
    Spencer TJ; Biederman J; Wilens TE; Faraone SV
    J Clin Psychiatry; 2002; 63 Suppl 12():16-22. PubMed ID: 12562057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.
    Osland ST; Steeves TD; Pringsheim T
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD007990. PubMed ID: 29944175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychopharmacology of ADHD: children and adolescents.
    Findling RL; Dogin JW
    J Clin Psychiatry; 1998; 59 Suppl 7():42-9. PubMed ID: 9680052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tic exacerbation and precipitation during atomoxetine treatment in two children with attention-deficit hyperactivity disorder.
    Párraga HC; Párraga MI; Harris DK
    Int J Psychiatry Med; 2007; 37(4):415-24. PubMed ID: 18441629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-stimulant treatment of attention-deficit/hyperactivity disorder.
    Pliszka SR
    CNS Spectr; 2003 Apr; 8(4):253-8. PubMed ID: 12679740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders.
    Pringsheim T; Steeves T
    Cochrane Database Syst Rev; 2011 Apr; (4):CD007990. PubMed ID: 21491404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADHD treatment across the life cycle.
    Spencer TJ
    J Clin Psychiatry; 2004; 65 Suppl 3():22-6. PubMed ID: 15046532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis with focus on bupropion.
    Stuhec M; Munda B; Svab V; Locatelli I
    J Affect Disord; 2015 Jun; 178():149-59. PubMed ID: 25813457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.
    Garnock-Jones KP; Keating GM
    Paediatr Drugs; 2009; 11(3):203-26. PubMed ID: 19445548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressants in the treatment of attention-deficit/hyperactivity disorder.
    Popper CW
    J Clin Psychiatry; 1997; 58 Suppl 14():14-29; discussion 30-1. PubMed ID: 9418743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological treatment of attention-deficit/hyperactivity disorder in adults.
    Slatkoff J; Greenfield B
    Expert Opin Investig Drugs; 2006 Jun; 15(6):649-67. PubMed ID: 16732717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of adult ADHD and comorbid disorders.
    Young JL
    CNS Spectr; 2006 Oct; 11(10 Suppl 11):10-2. PubMed ID: 17712918
    [No Abstract]   [Full Text] [Related]  

  • 14. Antidepressants in the treatment of adult attention-deficit hyperactivity disorder: a systematic review.
    Verbeeck W; Tuinier S; Bekkering GE
    Adv Ther; 2009 Feb; 26(2):170-84. PubMed ID: 19238340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders.
    Bloch MH; Panza KE; Landeros-Weisenberger A; Leckman JF
    J Am Acad Child Adolesc Psychiatry; 2009 Sep; 48(9):884-893. PubMed ID: 19625978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
    Faraone SV; Glatt SJ
    J Clin Psychiatry; 2010 Jun; 71(6):754-63. PubMed ID: 20051220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Atomoxetine (Strattera), an alternative in the treatment of attention-deficit/hyperactivity disorder (ADHD) in children].
    Gaillez C; Sorbara F; Perrin E
    Encephale; 2007 Sep; 33(4 Pt 1):621-8. PubMed ID: 18033153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adults.
    Santosh PJ; Sattar S; Canagaratnam M
    CNS Drugs; 2011 Sep; 25(9):737-63. PubMed ID: 21870887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic evidence synthesis of treatments for ADHD in children and adolescents: indirect treatment comparisons of lisdexamfetamine with methylphenidate and atomoxetine.
    Roskell NS; Setyawan J; Zimovetz EA; Hodgkins P
    Curr Med Res Opin; 2014 Aug; 30(8):1673-85. PubMed ID: 24627974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overdose of drugs for attention-deficit hyperactivity disorder: clinical presentation, mechanisms of toxicity, and management.
    Spiller HA; Hays HL; Aleguas A
    CNS Drugs; 2013 Jul; 27(7):531-43. PubMed ID: 23757186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.